Prospective Assessment of Tumour Burden and Bone Disease in Plasma Cell Dyscrasias Using DW-MRI and Exploratory Bone Biomarkers

SIMPLE SUMMARY: Whilst multiple myeloma (MM) remains incurable, two clinical priorities are to prolong remission and reduce complications, of which fragility fractures are a major source of morbidity. To this end, there is the need to develop biomarkers that can accurately track tumour burden and bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwal, Gaurav, Nador, Guido, Varghese, Sherin, Getu, Hiwot, Palmer, Charlotte, Watson, Edmund, Pereira, Claudio, Sallemi, Germana, Partington, Karen, Patel, Neel, Soundarajan, Rajkumar, Mills, Rebecca, Brouwer, Richard, Maritati, Marina, Shah, Aarti, Peppercorn, Delia, Oppermann, Udo, Edwards, Claire M., Rodgers, Christopher T., Javaid, Muhammad Kassim, Gooding, Sarah, Ramasamy, Karthik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817825/
https://www.ncbi.nlm.nih.gov/pubmed/36612090
http://dx.doi.org/10.3390/cancers15010095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817825/
https://www.ncbi.nlm.nih.gov/pubmed/36612090
http://dx.doi.org/10.3390/cancers15010095

Ejemplares similares